Global Antibiotic R&D Partnership (GARDP)
Ravindra P. Jumde is a Scientific Senior Officer at Global Antibiotic R&D Partnership (GARDP) with a background in drug design and development for bacterial and viral enzymes. Prior to this, Ravindra worked as a Project leader at Helmholtz Institute for Pharmaceutical Research Saarland and as a Science Writer at Saarland University. With a Ph.D. in Chemistry from Università di Pisa and experience in postdoctoral research at University of Groningen and National Research Council of Italy, Ravindra has a strong foundation in organic chemistry and catalytic methodologies.
This person is not in any offices
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org